Selskabets formål er at drive virksomhed inden for design, udvikling og kliniske undersøgelser af vacciner samt at drive anden i forbindelse hermed stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -9.2 mio. | -19.8 mio. | 7.3 mio. | 3.5 mio. | 6 |
CVR: 44372835
Secondary names: NVAC P/S
Previous names: NVAC P/S
Compared to 1.019 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Nadia Gabriela Tornieporth joined the board
Arnauld Michel Didierlaurent joined the board
Erika Johanna Söderberg Johnsson left the board
Peter Andersen joined the board
Pelle Kristoffer Munk-Poulsen joined the board
Else Marie Hansen joined as ADM. DIR.
Peter Andersen left the board
Pelle Kristoffer Munk-Poulsen left the board
Erika Johanna Söderberg Johnsson left as ADM. DIR.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 42666084
CVR 27701396
companydata.dk